Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reifenberger

Showing results (311-320 of 562) with videos related to

Pageof 57
Sort By:
Brain Pathology (Zurich, Switzerland)|June 15, 2004
Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survivalJörg Felsberg, Angelika Erkwoh, Michael C Sabel, et al.
The American Journal of Pathology|September 1, 1997
Molecular genetic analysis of giant cell glioblastomasB Meyer-Puttlitz, Y Hayashi, A Waha, et al.
International Journal of Cancer|March 22, 2006
Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profilingBjoern Tews, Joerg Felsberg, Christian Hartmann, et al.
Clinical Neuropathology|May 1, 1995
The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trialR Schober, T Bilzer, A Waha, et al.
International Journal of Cancer|August 11, 2007
Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomasEva M Grasbon-Frodl, Friedrich Wilhelm Kreth, Michael Ruiter, et al.
International Journal of Cancer|February 8, 2007
Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumorsDetlef Trost, Marion Ehrler, Rolf Fimmers, et al.
Journal of Neurosurgery|August 10, 2000
Multiple intracranial juvenile xanthogranulomas. Case reportJ Boström, G Janssen, M Messing-Jünger, et al.
Nature Reviews. Neurology|June 11, 2014
MGMT testing--the challenges for biomarker-based glioma treatmentWolfgang Wick, Michael Weller, Martin van den Bent, et al.
Anticancer Research|March 8, 2011
Influencing the Wnt signaling pathway in multiple myelomaYoung Kim, Guido Reifenberger, Desheng Lu, et al.
Nature Reviews. Disease Primers|May 19, 2016
GliomaMichael Weller, Wolfgang Wick, Ken Aldape, et al.
Pageof 57

Showing results (311-320 of 562) with videos related to

Sort By:
Pageof 57
Brain Pathology (Zurich, Switzerland)|June 15, 2004
Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survivalJörg Felsberg, Angelika Erkwoh, Michael C Sabel, et al.
The American Journal of Pathology|September 1, 1997
Molecular genetic analysis of giant cell glioblastomasB Meyer-Puttlitz, Y Hayashi, A Waha, et al.
International Journal of Cancer|March 22, 2006
Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profilingBjoern Tews, Joerg Felsberg, Christian Hartmann, et al.
Clinical Neuropathology|May 1, 1995
The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trialR Schober, T Bilzer, A Waha, et al.
International Journal of Cancer|August 11, 2007
Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomasEva M Grasbon-Frodl, Friedrich Wilhelm Kreth, Michael Ruiter, et al.
International Journal of Cancer|February 8, 2007
Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumorsDetlef Trost, Marion Ehrler, Rolf Fimmers, et al.
Journal of Neurosurgery|August 10, 2000
Multiple intracranial juvenile xanthogranulomas. Case reportJ Boström, G Janssen, M Messing-Jünger, et al.
Nature Reviews. Neurology|June 11, 2014
MGMT testing--the challenges for biomarker-based glioma treatmentWolfgang Wick, Michael Weller, Martin van den Bent, et al.
Anticancer Research|March 8, 2011
Influencing the Wnt signaling pathway in multiple myelomaYoung Kim, Guido Reifenberger, Desheng Lu, et al.
Nature Reviews. Disease Primers|May 19, 2016
GliomaMichael Weller, Wolfgang Wick, Ken Aldape, et al.
Pageof 57